These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33164665)

  • 21. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
    Sherwin J; Heath T; Watt K
    Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics.
    Udy AA; Roberts JA; Lipman J; Blot S
    Adv Drug Deliv Rev; 2018 Jan; 123():65-74. PubMed ID: 28964882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.
    Yu T; Stockmann C; Healy DP; Olson J; Wead S; Neely AN; Kagan RJ; Spigarelli MG; Sherwin CM
    J Burn Care Res; 2015; 36(4):e244-52. PubMed ID: 25185930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fungal Infections in Burn Patients.
    Palackic A; Popp D; Tapking C; Houschyar KS; Branski LK
    Surg Infect (Larchmt); 2021 Feb; 22(1):83-87. PubMed ID: 33035112
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients.
    Morales Junior R; Telles JP; Kwiatkowski SY; Juodinis VD; de Souza DC; Santos SRCJ
    Liver Transpl; 2023 Jan; 29(1):91-102. PubMed ID: 35643926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choice of antibiotics, pharmacokinetics, and dose adjustments in acute and chronic renal failure.
    Bernstein JM; Erk SD
    Med Clin North Am; 1990 Jul; 74(4):1059-76. PubMed ID: 2195257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and safety of antimicrobial agents during pregnancy.
    Chow AW; Jewesson PJ
    Rev Infect Dis; 1985; 7(3):287-313. PubMed ID: 3895351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial Agent Dosing in Infants.
    Johnson JK; Laughon MM
    Clin Ther; 2016 Sep; 38(9):1948-60. PubMed ID: 27473383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatment recommendations for topical burn therapy.
    Monafo WW; West MA
    Drugs; 1990 Sep; 40(3):364-73. PubMed ID: 2226220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of Antimicrobials in Obese Children.
    Sampson M; Cohen-Wolkowiez M; Benjamin D; Capparelli E; Watt K
    GaBI J; 2013; 2(2):76-81. PubMed ID: 25009734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of systemically administered antibiotics in patients with thermal injury.
    Boucher BA; Kuhl DA; Hickerson WL
    Clin Infect Dis; 1992 Feb; 14(2):458-63. PubMed ID: 1554831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel).
    Chalekson CP; Neumeister MW; Jaynes J
    Plast Reconstr Surg; 2002 Apr; 109(4):1338-43. PubMed ID: 11964988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of colistin in an adolescent boy with extensive burn injury.
    Healy DP; Sombun AD; Gardner JC; Good K; Durkee PJ; Toner L; Rieman MT; Neely AN; Kagan RJ
    J Burn Care Res; 2011; 32(1):e7-11. PubMed ID: 21099435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Burn Infection.
    Williams FN; Lee JO
    Surg Infect (Larchmt); 2021 Feb; 22(1):54-57. PubMed ID: 32790497
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial Pharmacokinetics and Pharmacodynamics.
    Jarrell AS; Kruer RM; Johnson D; Lipsett PA
    Surg Infect (Larchmt); 2015 Aug; 16(4):375-9. PubMed ID: 26207398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.